Abstract
Potent and noncovalent inhibitors of caspase-1 were produced by incorporating a secondary amine (reduced amide) isostere in place of the conventional electrophile (e.g., aldehyde) that normally confers high potency to cysteine protease inhibitors. Benzyl- or cyclohexylamines produced potent, reversible, and competitive inhibitors that were selective for caspase-1 (e.g., Ki = 47 nM) over caspases 3 and 8 with minimal cytotoxicity. Unlike most cysteine protease inhibitors, these compounds do not react covalently and indiscriminately with thiols.
Original language | English |
---|---|
Pages (from-to) | 2651-2655 |
Number of pages | 5 |
Journal | Journal of Medicinal Chemistry |
Volume | 53 |
Issue number | 6 |
DOIs | |
Publication status | Published - 25 Mar 2010 |
Externally published | Yes |